284 related articles for article (PubMed ID: 21088425)
21. The role of axillary lymph node dissection in breast cancer patients with sentinel lymph node micrometastases.
Gipponi M; Canavese G; Lionetto R; Catturich A; Vecchio C; Sapino A; Friedman D; Cafiero F
Eur J Surg Oncol; 2006 Mar; 32(2):143-7. PubMed ID: 16300921
[TBL] [Abstract][Full Text] [Related]
22. Erratum to: Axillary recurrence rate following negative sentinel node biopsy for invasive breast cancer: long-term follow-up.
Kiluk JV; Ly QP; Santillan AA; Meade T; Ramos D; Reintgen DS; Dessureault S; Davis M; Shamehdi C; Cox CE
Ann Surg Oncol; 2010 Feb; 17(2):552-7. PubMed ID: 19957043
[TBL] [Abstract][Full Text] [Related]
23. The likelihood of additional nodal disease following a positive sentinel lymph node biopsy in breast cancer patients: validation of a nomogram.
Cripe MH; Beran LC; Liang WC; Sickle-Santanello BJ
Am J Surg; 2006 Oct; 192(4):484-7. PubMed ID: 16978955
[TBL] [Abstract][Full Text] [Related]
24. Prediction of additional axillary metastasis of breast cancer following sentinel lymph node surgery.
Changsri C; Prakash S; Sandweiss L; Bose S
Breast J; 2004; 10(5):392-7. PubMed ID: 15327491
[TBL] [Abstract][Full Text] [Related]
25. Sentinel lymph node biopsy is associated with improved survival compared to level I & II axillary lymph node dissection in node negative breast cancer patients.
Langer I; Guller U; Hsu-Schmitz SF; Ladewig A; Viehl CT; Moch H; Wight E; Harder F; Oertli D; Zuber M
Eur J Surg Oncol; 2009 Aug; 35(8):805-13. PubMed ID: 19046846
[TBL] [Abstract][Full Text] [Related]
26. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR
Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302
[TBL] [Abstract][Full Text] [Related]
27. Factors associated with involvement of four or more axillary nodes for sentinel lymph node-positive patients.
Katz A; Niemierko A; Gage I; Evans S; Shaffer M; Smith FP; Taghian A; Magnant C
Int J Radiat Oncol Biol Phys; 2006 May; 65(1):40-4. PubMed ID: 16488555
[TBL] [Abstract][Full Text] [Related]
28. Prediction of tumour involvement in remaining axillary lymph nodes when the sentinel node in a woman with breast cancer contains metastases.
Nos C; Harding-MacKean C; Fréneaux P; Trie A; Falcou MC; Sastre-Garau X; Clough KB
Br J Surg; 2003 Nov; 90(11):1354-60. PubMed ID: 14598414
[TBL] [Abstract][Full Text] [Related]
29. Nonsentinel node metastases in breast cancer patients with isolated tumor cells in the sentinel node: implications for completion axillary node dissection.
Calhoun KE; Hansen NM; Turner RR; Giuliano AE
Am J Surg; 2005 Oct; 190(4):588-91. PubMed ID: 16164927
[TBL] [Abstract][Full Text] [Related]
30. Predictors of nonsentinel node metastasis in patients with breast cancer after sentinel node metastasis.
Joseph KA; El-Tamer M; Komenaka I; Troxel A; Ditkoff BA; Schnabel F
Arch Surg; 2004 Jun; 139(6):648-51. PubMed ID: 15197092
[TBL] [Abstract][Full Text] [Related]
31. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
[TBL] [Abstract][Full Text] [Related]
32. Sentinel lymphadenectomy for breast cancer in a community managed care setting.
Guenther JM; Krishnamoorthy M; Tan LR
Cancer J Sci Am; 1997; 3(6):336-40. PubMed ID: 9403045
[TBL] [Abstract][Full Text] [Related]
33. Sentinel lymph-node biopsy compared to axillary lymph-node dissection for axillary staging in breast cancer patients.
Schrenk P; Shamiyeh A; Wayand W
Eur J Surg Oncol; 2001 Jun; 27(4):378-82. PubMed ID: 11417984
[TBL] [Abstract][Full Text] [Related]
34. Study finds omission of axillary lymph node dissection safe for patients with sentinel node micrometastases.
Dreyfuss JH
CA Cancer J Clin; 2010; 60(1):2-3. PubMed ID: 20018977
[No Abstract] [Full Text] [Related]
35. A Randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: results of the Sentinella/GIVOM trial.
Zavagno G; De Salvo GL; Scalco G; Bozza F; Barutta L; Del Bianco P; Renier M; Racano C; Carraro P; Nitti D;
Ann Surg; 2008 Feb; 247(2):207-13. PubMed ID: 18216523
[TBL] [Abstract][Full Text] [Related]
36. Axillary recurrence is low in patients with breast cancer who do not undergo completion axillary lymph node dissection for micrometastases in sentinel lymph nodes.
Rayhanabad J; Yegiyants S; Putchakayala K; Haig P; Romero L; Difronzo LA
Am Surg; 2010 Oct; 76(10):1088-91. PubMed ID: 21105616
[TBL] [Abstract][Full Text] [Related]
37. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
38. The incidence and significance of micrometastases in lymph nodes of patients with ductal carcinoma in situ and T1a carcinoma of the breast.
Broekhuizen LN; Wijsman JH; Peterse JL; Rutgers EJ
Eur J Surg Oncol; 2006 Jun; 32(5):502-6. PubMed ID: 16569492
[TBL] [Abstract][Full Text] [Related]
39. Lymphatic mapping and sentinel lymphadenectomy in early stage breast carcinoma.
Altinyollar H; Kapucuoglu N; Pak I; Berberoglu U
J Exp Clin Cancer Res; 2000 Jun; 19(2):141-4. PubMed ID: 10965808
[TBL] [Abstract][Full Text] [Related]
40. Sentinel node mapping for breast cancer: the operative experience of a breast surgeon in a rural community.
Davit FE; Gatmaitan P; Garguilo G
Am Surg; 2008 May; 74(5):423-7. PubMed ID: 18481500
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
